Skip to main content

4 Result(s)

within Anna Alkelai Remove this filter Neurosciences Remove this filter

and

  1. Article

    Erratum to: Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients

    Lior Greenbaum, Robert C. Smith, Mordechai Lorberboym, Anna Alkelai… in Psychopharmacology (2012)

    Download PDF (56 KB) View Article

  2. No Access

    Article

    Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients

    Antipsychotic-induced parkinsonism (AIP) is a severe adverse affect of antipsychotic drug treatment. Recently, our group performed a genome-wide association study (GWAS) for AIP severity, and identified severa...

    Lior Greenbaum, Robert C. Smith, Mordechai Lorberboym, Anna Alkelai… in Psychopharmacology (2012)

  3. No Access

    Article

    Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis

    Reelin (RELN) is identified as a risk gene for major psychiatric disorders such as schizophrenia (SCZ) and bipolar disorder (BPD). However, the role of its downstream signaling molecule, the low-density lipopr...

    Ming Li, Liang Huang, Maria Grigoroiu-Serbanescu, Sarah E. Bergen… in Molecular Neurobiology (2016)

  4. No Access

    Article

    The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

    Schizophrenia has a multifactorial etiology, involving a polygenic architecture. The potential benefit of whole genome sequencing (WGS) in schizophrenia and other psychotic disorders is not well studied. We in...

    Anna Alkelai, Lior Greenbaum, Anna R. Docherty, Andrey A. Shabalin… in Molecular Psychiatry (2022)